Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer.
about
miR-200 enhances mouse breast cancer cell colonization to form distant metastasesThe epithelial-mesenchymal transition (EMT) phenomenonCancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lungA reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cellsThe miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease ProgressionMechanisms of TGFβ-Induced Epithelial-Mesenchymal TransitionRebuilding cancer metastasis in the mouseOn the origin of cancer metastasisEpithelial cell polarity determinant CRB3 in cancer developmentRole of cancer microenvironment in metastasis: focus on colon cancerSelf-Styled ZnO Nanostructures Promotes the Cancer Cell Damage and Supresses the Epithelial Phenotype of GlioblastomaTrailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer CellsThe Regulatory Role of MicroRNAs in EMT and CancerDifferential effect of growth factors on invasion and proliferation of endocrine resistant breast cancer cellsComparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasionEpithelial-mesenchymal transition associates with maintenance of stemness in spheroid-derived stem-like colon cancer cells.Epithelial to mesenchymal transition of a primary prostate cell line with switches of cell adhesion modules but without malignant transformation.Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinomaConfocal images of circulating tumor cells obtained using a methodology and technology that removes normal cellsEpithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis.Subcellular proteomics revealed the epithelial-mesenchymal transition phenotype in lung cancer.Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulatorsInvolvement of members of the cadherin superfamily in cancerEstrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells.Role of emmprin in endometrial cancerDisabled-2 downregulation promotes epithelial-to-mesenchymal transitionSurfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasisIncreased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer.Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma.WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade.An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition.Impact of p120-catenin isoforms 1A and 3A on epithelial mesenchymal transition of lung cancer cells expressing E-cadherin in different subcellular locationsThree interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells.G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinomaProgression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer.MET receptor is a potential therapeutic target in high grade cervical cancerThe EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitorsMultiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck
P2860
Q21091183-13E1027A-2B48-4688-8C60-B7220F3ABE2DQ24600898-95A67F97-02EE-48E9-A349-1A5B2082AB90Q24628819-405BCA44-FC1A-47FD-8E2A-540AF3791C85Q24647117-C8E3124C-CEFA-4CEF-9722-A88959A16B57Q24649109-4BBD3670-67C4-4029-8BF3-00A2F100A2D6Q26744831-56D7191C-3FBD-4015-8ED1-AFE7E88EF8FBQ26745545-1A1E93F1-7DD4-4D78-B617-22D67FF0F7E1Q26864450-AE32D26A-C49F-439C-921A-ECBD92157880Q26865675-3AF7803D-1ADB-4CF8-9664-C53EF00194CFQ27004735-D9AE4A9E-451E-4EB7-B69B-1022485EFDB8Q28239062-97BFC528-84A1-4189-9D9A-6CA4A015268DQ28385157-4F7493FC-E3D5-4FBD-A2B0-1083F12F510EQ28391040-5C5D3399-A143-4CF7-AE43-665E42C41404Q28391426-E605733B-2735-421B-AECE-5F031807273AQ28481683-654A40C2-8B03-4FA1-AACD-E4DC2CE5D655Q30490521-420AFA51-4970-41E0-9FF1-FF3BA16362CDQ31138688-F9740581-A165-4EBF-9B01-71EC67BF290EQ33375703-52A26158-4A5A-4AC9-B54F-9341307ADD9DQ33646333-53DC238E-22F7-4664-BA08-2B725BA543C9Q33691179-1F9B0F99-5740-4E4D-92CF-4743348BBFC6Q33751266-BDFA7D9F-A27B-4501-ADA4-E4AFC5B1AB11Q33804107-F6A01985-6AD4-4922-B827-0B16CC581B46Q33852611-E3A9C1DF-06FD-4364-B32B-8799AC39E57FQ33899441-4F24D693-5610-4D60-B381-7340EFB4AB1DQ33945493-DD7D7EF0-F08D-40EE-8616-05CCBACDB20BQ34284285-CBF29C3A-51A2-4578-BA11-3FA684A3CDE8Q34363558-532514F3-8E00-4FA6-B11E-1D5E29332118Q34391559-A6F09451-655B-4403-8056-05D27F9E9DF8Q34404867-5840CED0-D722-4CC9-98EF-CE679AFD16E1Q34507203-0F7AE751-4115-48A2-804D-FB1FA0FA4560Q34842373-72514AAC-5AF7-4852-AE4F-F82BEA8A91B1Q34977307-57ED2B5C-42EE-42CB-B679-6CBBAED8A3DAQ35088454-7A2295D9-E63A-4ECB-B6AC-C6E83A45F346Q35683502-D7549DE1-7128-42EF-ABCF-FB9D8373B24FQ35740098-1BC197CF-D859-4676-A526-40C03B47E3F8Q35758432-2FFDDA7E-3FEE-40ED-BE5B-B0D841B678BDQ35818402-5DABBEC6-5FE1-49C5-B617-D6F428EDC329Q35832923-7D119D0F-A966-4759-9190-194476380FC2Q35987369-024FEA34-E666-4678-A5DC-3E6DCC49608AQ36120034-FAD738E8-6B87-414A-957A-BB0182C986B8
P2860
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer.
@en
type
label
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer.
@en
prefLabel
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer.
@en
P2093
P2860
P1476
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer
@en
P2093
Eric Raspé
Gerhard Christofori
Jean Paul Thiery
P2860
P2888
P304
P356
10.1007/S10585-007-9114-6
P577
2007-11-03T00:00:00Z